USPTO serial 99023400
ATLAS
Reviewed by CopyMark Law Group
Status 651
- Filing date
- Status date
- Registration date
- —
- Examiner
- PAQUIN, SAMUEL ROBERT
- Law office
- TMEG LAW OFFICE 101
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ATLAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software using artificial intelligence and machine learning for providing and facilitating medical diagnosis, for managing and analysing medical data, and for managing data and physician and patient communications related to clinical trials, and for managing data and communications of pharmaceutical, scientific, biological and clinical research, all of the foregoing for use in the fields of pathology, medical research, drug discovery and development; downloadable software for the integration of artificial intelligence and machine learning in the field of medical data | ACTIVE | — |
| 042 | Development of software in the field of artificial intelligence technology for the analysis of medical data; research in the field of artificial intelligence technology for the analysis of medical data; providing temporary use of online non-downloadable computer programs using artificial intelligence for the analysis of medical data; Software as a service (SAAS) featuring software for processing, diagnosing and analyzing medical data using machine learning algorithms and artificial intelligence; AI-software based analysis of human tissues for medical research; AI-software based analysis of human serum for medical research; AI-software based medical and pharmacological research services; provision of information and data relating to AI-software based medical research; AI-software based clinical research in the fields of pathology, histology, oncology, and drug discovery and development; AI-software based medical and scientific research, namely, conducting clinical trials for others; biological research, clinical research in the fields of pathology, histology, oncology, drug discovery, drug development and medical research, all AI-software based; AI-software based scientific research in the nature of conducting clinical trials for others for pharmaceutical products | ACTIVE | — |
| 044 | Medical diagnostic testing services; medical analysis services for cancer diagnosis and prognosis; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; all the above services using artificial intelligence and machine learning | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 31, 2026 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 31, 2026 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 31, 2026 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 30, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 2, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 2, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 2, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Sep 29, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 29, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2025 | NWAP | NEW APPLICATION ENTERED | — |